ChemicalBook--->CAS DataBase List--->87725-72-2

87725-72-2

87725-72-2 Structure

87725-72-2 Structure
IdentificationBack Directory
[Name]

QNSWMJYOGMUVGO-REWXTUPXSA-N
[CAS]

87725-72-2
[Synonyms]

QNSWMJYOGMUVGO-REWXTUPXSA-N
[Molecular Formula]

C24H35ClN2O5
[MOL File]

87725-72-2.mol
[Molecular Weight]

466.998
Hazard InformationBack Directory
[Uses]

Trandolapril Hydrochloride is an antihypertensive. Angiotensin converting enzyme (ACE) inhibitor.
[in vivo]

Trandolapril hydrochloride (3 mg/kg/day; p.o.; 7 d) reduces renal fibrosis in obstructive nephropathy in mice, by inhibiting renal interstitial matrix expression and myofibroblast activation, decreasing renal proinflammatory cytokine RANTES and TNF-α level[2].
Trandolapril hydrochloride (0.3 mg/kg/day; p.o.; 4 weeks) improves arterial mechanics in rats, prevents arterial hypertrophy, collagen and cellular fibronectin accumulation[3].
randolapril (0.3 mg/kg/day; p.o.; 4 months) exhibits a chronic anti-hypertension effects in rats, results in blood pressure decreasing[3].
Trandolapril hydrochloride (0.25 mg/kg; p.o.; twice a day; 4 months) inhibits Atherosclerosis in the Watanabe Heritable Hyperlipidemic Rabbit[4].

Animal Model:UUD (unilateral ureteral obstruction) model in Male CD-1 mice (18-22 g)[2]
Dosage:3 mg/kg
Administration:Oral gavage; daily, for 7 days
Result:Resulted in renal interstitial matrix expression (including fibronectin, type I, and type III collagen) decreasing, and inhibited myofibroblast activation by surprising a-smooth muscle actin (a-SMA) expression, decreased the RANTES (regulated on activation, normal T cell expressed and secreted) and TNF-α level.
Animal Model:SHR model (spontaneously hypertensive rats, 4-week-old)[3]
Dosage:0.3 mg/kg
Administration:Oral gavage; daily for 4 weeks
Result:Reduced collagen content in the aortic media and increased ariterial distensibility up to about 80%.
Animal Model:Watanabe heritable hyperlipidemic rabbit (3 months old)[4]
Dosage:0.25 mg/kg
Administration:Oral gavage; twice a day; 9 months
Result:Decreased in atherosclerotic involvement of the intimal surface, and also decreased cholesterol content in descending thoracic aorta.
87725-72-2 suppliers list
Company Name: TargetMol Chemicals Inc.
Tel: +17819995354 , +17819995354
Website:
Company Name: Energy Chemical  
Tel: 021-58432009 400-005-6266
Website: http://www.energy-chemical.com
Company Name: TargetMol Chemicals Inc.  
Tel: 15002134094
Website: https://www.targetmol.cn/
Company Name: Santa Cruz Biotechnology Inc  
Tel: 021-60936350
Website: www.scbt.com
Company Name: Pharma Affiliates  
Tel: 172-5066494
Website: www.chemicalbook.com/ShowSupplierProductsList694812/0_EN.htm
Company Name: Pharmaffiliates Analytics and Synthetics P. Ltd  
Tel: +91-172-5066494
Website: www.pharmaffiliates.com
Company Name: CLEARSYNTH LABS LTD.  
Tel: +91-22-45045900
Website: www.clearsynth.com
Tags:87725-72-2 Related Product Information
1356019-55-0 159326-68-8 1795142-64-1 1797984-80-5 1794829-04-1